ELCO Management’s GSK GSK Stock Holding History

ELCO Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,933	Closed	-$243K	–	166
2024 Q3	$243K	Sell	5,933 -175	-3%	-$7.16K	0.13%	140
2024 Q2	$235K	Sell	6,108 -3,055	-33%	-$129K	0.14%	129
2024 Q1	$393K	Sell	9,163 -1,670	-15%	-$68.9K	0.24%	96
2023 Q4	$401K	Hold	10,833	–	–	0.26%	89
2023 Q3	$393K	Sell	10,833 -1,185	-10%	-$42.1K	0.28%	78
2023 Q2	$428K	Sell	12,018 -567	-5%	-$20.3K	0.31%	74
2023 Q1	$448K	Buy	+12,585	New	+$440K	0.33%	71

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ELCO Management's GSK Position: Q4 2024 in Review

ELCO Management sold out of GSK (GSK) in Q4 2024, closing a stake of 5,933 shares — an estimated $243K sold.

ELCO Management first reported a position in GSK in Q1 2023 and held it in 7 quarters. The position peaked at $448K in Q1 2023. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

ELCO Management reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
ELCO Management sold 5,933 GSK shares in Q4 2024, an estimated $243K.
ELCO Management first reported a position in GSK in Q1 2023 and held it in 7 quarters.
ELCO Management's GSK position peaked at $448K in Q1 2023.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on ELCO Management's 13F filing for Q4 2024, filed 13 Feb 2025.